Compounding Advocacy Group Has New Name, Website
Members of the International Academy of Compounding Pharmacists voted to change the association's name to the Alliance for Pharmacy Compounding.
Michigan Residents Receive Free PrEP Through Federal Program
Through the Ready, Set, PrEP program, qualified patients from across the United States can access PrEP medication for the prevention of HIV, for free.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
What pharmacist created the famous soda, Coca-Cola, on May 8, 1886?
Dawn Hershman, MD, MS, offers some potential treatments for aromatase inhibitor-caused arthralgia in breast cancer patients. This video was filmed at the 2019 San Antonio Breast Cancer Symposium.
Counties in Medicaid expansion states saw an 11% lower rate of heroin deaths and a 10% lower rate of deaths involving synthetic opioids compared with counties in non-expansion states.
Tofacitinib, currently used to treat rheumatoid arthritis and ulcerative colitis, has a correcting effect on defects that occur in inflammation.
NDMA contamination in medications has caused concern among consumers, and health care professionals after WHO recalled 1159 lots of ARBs including valsartan, losartan, and irbesartan.
Top news of the day from across the health care landscape.
Starting January 2020, aspiring certified pharmacy technicians must complete a Pharmacy Technician Certification Exam-recognized education or training program, or have equivalent work experience before taking the exam.
The statement pointed out that the spread of legalized marijuana products has increased the need for unified labeling requirements.
The emergence of a new Medicare Advantage plan, Troy Medicare, offers much needed momentum to drive pharmacists’ services.
The researchers found that the likelihood of being hospitalized for a somatic disease was just as high during the periods when the patients were on antipsychotic drugs as when they were not; however, the differences in mortality were clear.
A discussion of the PAOLO-1 trial regimen and the rationale behind combining olaparib and bevacizumab as post-chemotherapy maintenance.
The Importance of Cross-Functional Collaboration in Revenue Integrity
Girish Dighe, PharmD, MS, explains why it is important to understand more than just the revenue integrity piece of the puzzle.